WASHINGTON — The Pediatric Brain Tumor Consortium is a network of academic centers and children’s hospitals across the U.S. and Canada that has worked for more than a quarter century to advance new treatments for brain cancer in kids.

Jason Fangusaro, the consortium’s national vice chair, confirmed the group is losing federal funding provided by the National Cancer Institute and will dissolve. The update was first reported by Endpoints News.

The PBTC was informed that it would not be able to apply for funding beyond March 2026, and the PBTC has closed all trials to new enrollments, Fangusaro said.

“I am deeply saddened by this decision by the NCI,” he said in a statement. “The PBTC has contributed significantly to the advancement of clinical trials, innovation, and science within t

See Full Page